Table 2.
Prevalence of 25(OH)D Deficiency: < 50 nmol/L (20 ng/mL); and Deficiency + Insufficiency: < 75 nmol/L (30 ng/mL) in the DHS1 and DHS2, unadjusted data
| DHS1 | DHS2 | |||
|---|---|---|---|---|
|
|
|
|||
| < 50 nmol/l | < 75 nmol/l | < 50 nmol/l | < 75 nmol/l | |
|
|
|
|||
| Overall | 1240 (60.6%) | 1791 (87.6%) | 1358 (66.4%) | 1845 (90.2%) |
|
| ||||
| Black | 838 (81.4%) | 1000 (97.2%) | 834 (69.8%) | 997 (96.9%) |
|
| ||||
| White | 204 (29.9%) | 485 (71.1%) | 297 (43.5%) | 533 (78.2%) |
|
| ||||
| Hispanic | 175 (59.7%) | 273 (93.2%) | 200 (68.3%) | 278 (94.9%) |
|
| ||||
| Men | 426 (50.1%) | 716 (84.1%) | 524 (61.6%) | 759 (89.2%) |
|
| ||||
| Black | 267 (70.6%) | 357 (94.4%) | 293 (77.5%) | 368 (97.4%) |
|
| ||||
| White | 82 (25.7%) | 222 (69.6%) | 132 (41.4%) | 247 (77.4%) |
|
| ||||
| Hispanic | 61 (47.7%) | 116 (90.6%) | 79 (61.7%) | 120 (93.8%) |
|
| ||||
| Women | 814 (68.2%) | 1075 (90.0%) | 834 (69.8%) | 1086 (91.0%) |
|
| ||||
| Black | 571 (87.7%) | 643 (98.8%) | 541 (83.1%) | 629 (96.6%) |
|
| ||||
| White | 122 (33.6%) | 263 (72.5%) | 165 (45.5%) | 286 (78.8%) |
|
| ||||
| Hispanic | 114 (69.1%) | 157 (95.2%) | 121 (73.3%) | 158 (95.8%) |
|
| ||||
| Age (years) | ||||
|
| ||||
| < 40 | 486 (61.5%) | 698 (88.4%) | 225 (70.3%) | 293 (91.6%) |
|
| ||||
| 41–50 | 411 (61.4%) | 577 (86.2%) | 450 (70.8%) | 587 (92.3%) |
|
| ||||
| 51–60 | 283 (58.7%) | 421 (87.3%) | 422 (63.5%) | 594 (89.3%) |
|
| ||||
| > 60 | 60 (57.7%) | 95 (91.3%) | 261 (61.6%) | 371 (87.5%) |
|
| ||||
| Body Mass Index (kg/m2) | ||||
|
| ||||
| < 25 | 254 (46.1%) | 430 (78.0%) | 214 (56.9%) | 304 (80.9%) |
|
| ||||
| 25–30 | 373 (56.2%) | 576 (86.7%) | 389 (61.3%) | 565 (89.0%) |
|
| ||||
| ≥ 30 | 602 (73.7%) | 772 (94.5%) | 750 (73%) | 970 (94.5%) |